Besides, CD44 and ALDH1 are considered as specific markers of CSCs in colon cancer25, gastric cancer26, and squamous cell carcinoma27, the expression of ALDH1 in breast cancer may contribute to a more aggressive phenotype28. This evidence concerns the gene CD44 and breast cancer.